The NADPARK study: A randomized phase I trial of nicotinamide riboside supplementation in Parkinson’s disease
- Resource Type
- Short Communication
- Authors
- Brakedal, Brage; Dölle, Christian; Riemer, Frank; Ma, Yilong; Nido, Gonzalo S.; Skeie, Geir Olve; Craven, Alexander R.; Schwarzlmüller, Thomas; Brekke, Njål; Diab, Joseph; Sverkeli, Lars; Skjeie, Vivian; Varhaug, Kristin; Tysnes, Ole-Bjørn; Peng, Shichun; Haugarvoll, Kristoffer; Ziegler, Mathias; Grüner, Renate; Eidelberg, David; Tzoulis, Charalampos
- Source
- In Cell Metabolism 1 March 2022 34(3):396-407
- Subject
- Language
- ISSN
- 1550-4131